Neupsy Key

div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_19 19. Adjunctive Medications Oliver Freudenreich1  (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA   KeywordsAdd-on strategiesNonpsychotic symptom clustersDepressionAntidepressantsAnxiolyticsBenzodiazepine indicationsInsomniaSedative-hypnoticsAntiepileptic drugsLithiumValproateCarbamazepineOxcarbazepineTopiramateAnticholinergicsHerbal…

div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_18 18. Long-Acting Injectable Antipsychotics Oliver Freudenreich1  (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA   KeywordsLong-acting injectable antipsychoticsLAIsRelapse preventionBenefitsIndicationsHarm reductionPatient…

div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_16 16. Antipsychotics: Clinical Effectiveness Oliver Freudenreich1  (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA   KeywordsLarge pragmatic trialsCATIEEvidence-based psychiatryClinical guidelinesSymptomatic…

div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_12 12. Treatment-Resistant Schizophrenia Oliver Freudenreich1  (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA   KeywordsTreatment-resistant schizophreniaPseudo-refractorinessTherapeutic drug monitoringLong-acting injectable antipsychotic…

div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020O. FreudenreichPsychotic DisordersCurrent Clinical Psychiatryhttps://doi.org/10.1007/978-3-030-29450-2_13 13. Antipsychotics: Overview Oliver Freudenreich1  (1) Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA   KeywordsAntipsychoticsDopamine-2 receptorMechanism of actionFirst-generation antipsychoticsSecond-generation antipsychoticsThird-generation…